Nevada
Provider Communications
Avastin Biosimilars Medical Step Therapy Notice
The clinical criteria below will be updated to include the requirement of a preferred agent effective
January 1, 2021.
Clinical criteria |
Preferred drug |
Nonpreferred drug |
ING-CC-0107 |
Mvasi (Q5107), Zirabev (Q5118) |
Avastin (J9035) |
The Clinical Criteria is publicly available on https://mediproviders.anthem.com/nv.
What if I need assistance?
If you have questions about this communication or need assistance with any other item, contact your local Provider Relations representative or call Provider Services toll free at 1-844-396-2330.
Featured In:
December 2020 Anthem Provider News and Important Updates -- Nevada